The Stratus immunofluorometric assay system evaluated for quantifying human choriogonadotropin in serum.

1986 ◽  
Vol 32 (7) ◽  
pp. 1402-1404 ◽  
Author(s):  
L C Rogers ◽  
S E Kahn ◽  
T H Oeser ◽  
E W Bermes
Keyword(s):  
Monoclonal Antibodies ◽  
Regression Equation ◽  
Assay System ◽  
Beta Subunit ◽  
The Other ◽  
Alpha Subunit ◽  
Human Choriogonadotropin ◽  
Beta Hcg

Abstract We evaluated the Stratus (American Dade, Miami, FL), an automated immunofluorometric assay system, for the quantification of human choriogonadotropin (hCG) in serum or plasma. The assay is based on the "sandwich" (two-site) immunoassay methodology: use of two monoclonal antibodies, one specific for the alpha subunit and the other for the beta subunit, results in an assay that is specific for the intact hCG molecule. Results for the first sample are obtained in 7 min; subsequent additional values are produced at 1-min intervals. Inter-run precision (CV), estimated from replicate determinations of sera, was 4.5% at an hCG concentration of 38 int. units/L, 4.9% at 114, and 6.1% at 194. Intrarun CV was less than 2% at all three concentrations. Correlations of results for 127 specimens analyzed in duplicate with the Stratus (y) and by a radioimmunoassay (x) for beta hCG (Gamma Dab M [cf931125I] beta-hCG, Travenol-Genentech Diagnostics, Cambridge, MA) yielded the following regression equation: y = 0.969x - 6.0 (r = 0.995). The Stratus immunofluorometric system provides a rapid and convenient assay of hCG in serum or plasma.

An evaluation of four serum tests for pregnancy.

1983 ◽  
Vol 29 (3) ◽  
pp. 561-563 ◽  
Author(s):  
K W Ryder ◽  
R A Munsick ◽  
T O Oei ◽  
P C Young ◽  
H F Blackford
Keyword(s):  
Positive Result ◽  
Early Pregnancy ◽  
Beta Subunit ◽  
The Other ◽  
Analytical Sensitivity ◽  
Negative Results ◽  
Human Choriogonadotropin ◽  
Beta Hcg

Abstract We evaluated four pregnancy tests (Biocept-G, Beta-CG, Preg/Stat, and HCG-Beta Screen), using sera from 59 nonpregnant subjects and 77 patients with serum human choriogonadotropin beta-subunit (beta-hCG) concentrations ranging from 4 to 100 000 int. units/L. The results obtained for each test were compared with the results predicted on the basis of the sample's beta-hCG concentration and the beta-hCG concentration the manufacturer claimed necessary for a positive result (the test's analytical sensitivity). Biocept-G had the best sensitivity (100%), specificity (98.9%), and accuracy (99.2%). Beta-CG had the poorest sensitivity (86.4%), Preg/Stat the poorest specificity (87.5%), and accuracy (92.6%). We confirmed the manufacturer's claimed analytical sensitivity (200 int. units/L) for the Biocept-G procedure, but our calculated analytical sensitivity for the other tests was significantly different from that claimed by their manufacturers. Best results were obtained with Biocept-G, but with its analytical sensitivity of 200 int. units/L, samples from early pregnancy will give negative results. None of the pregnancy tests evaluated here will establish the presence or absence of early pregnancy with certainty.

Epitope-selective, monoclonal-antibody-based immunoradiometric assays of predictable specificity for differential measurement of choriogonadotropin and its subunits.

1985 ◽  
Vol 31 (8) ◽  
pp. 1322-1328 ◽  
Author(s):  
S Schwarz ◽  
P Berger ◽  
G Wick
Keyword(s):  
Monoclonal Antibody ◽  
Monoclonal Antibodies ◽  
Conformational Epitope ◽  
Alpha Subunit ◽  
Beta Subunits ◽  
Differential Measurement ◽  
Analytical Strategy ◽  
Alpha Subunits ◽  
Human Choriogonadotropin ◽  
Beta Hcg

Abstract Knowing the epitope specificities of our monoclonal antibodies (MCA) to human choriogonadotropin (hCG), we could design three classes of two-site immunoradiometric assays (IRMA): a combination of two MCA recognizing two separate alpha-epitopes (alpha-MCA) provides a system (i.e., an alpha-IRMA) that measures holo-hCG plus free alpha-subunits plus follitropin, lutropin, and thyrotropin, whereas a beta-IRMA, consisting of two beta-MCA, quantifies holo-hCG plus free beta-subunits. The amount of either of the two subunits can be calculated by subtracting the amount of holo-hCG determined in parallel in a holo-hCG-IRMA. In the latter, one of the alpha- or beta-MCA may be either cross-combined or, preferably, paired with an MCA specific for a conformational epitope. These analytical specificities, predicted from our previously established epitope map of hCG, could be experimentally verified. With these IRMAS we could demonstrate that in certain choriocarcinoma cell lines the earliest and quantitatively predominant tumor marker is the free alpha-subunit. Similar results showing an unbalanced secretion of hCG and its subunits were obtained for patients with related tumors. These findings challenge the present diagnostic practice of relying solely on "beta-hCG" radioimmunoassays and at the same time offer a novel analytical strategy.

An accelerated enzyme immunoassay for human choriogonadotropin in urine, involving reflow of specimen through capillary tubes.

1987 ◽  
Vol 33 (4) ◽  
pp. 498-501 ◽  
Author(s):  
H M Chandler ◽  
S A Fuller ◽  
C H Nakagawa ◽  
P A Nagainis ◽  
J G Hurrell
Keyword(s):  
Monoclonal Antibody ◽  
Monoclonal Antibodies ◽  
Enzyme Immunoassay ◽  
Test Specimen ◽  
Capillary Tube ◽  
Test Procedure ◽  
Beta Subunit ◽  
Sensitive Assay ◽  
Substrate Solution ◽  
Human Choriogonadotropin

Abstract A very rapid and sensitive assay for human choriogonadotropin (hCG) has been developed involving two beta-subunit-specific monoclonal antibodies. In the assay the test specimen is passed backward and forward (reflow) through a monoclonal-antibody-coated capillary tube for 1 min, then incubated for 1 min with a second monoclonal antibody conjugated to urease (EC 3.5.1.5). After addition of a urease substrate solution, 10 int. units of hCG per liter can be detected visually within 5 min, which compares very favorably with other currently available hCG assay procedures. Advantages of the reflow/capillary tube assay system and optimization of the test procedure are discussed.

Evaluation of a solid-phase enzyme immunoassay for human choriogonadotropin beta subunit.

1983 ◽  
Vol 29 (11) ◽  
pp. 1964-1966 ◽  
Author(s):  
D D Davey ◽  
M M Sample ◽  
T O Oei
Keyword(s):  
Enzyme Immunoassay ◽  
Solid Phase ◽  
Cross Reactivity ◽  
Beta Subunit ◽  
Neoplastic Disease ◽  
Standard Curve ◽  
Human Choriogonadotropin ◽  
Beta Hcg ◽  
Substantial Problem ◽  
Sample Dilution

Abstract We evaluated a quantitative solid-phase enzyme immunoassay for human choriogonadotropin beta subunit (beta-HCG) with anti-beta-HCG:horseradish peroxidase conjugate, recently marketed by Abbott Laboratories. We compared results on 56 patients' serum specimens, obtained mostly for followup of neoplastic disease, with those by a competitive radioimmunoassay kit. The correlation was good, the differences being of little clinical significance. Linear regression in the low and intermediate ranges gave a slope of 0.93, a y-intercept of 0.34, and a correlation coefficient of 0.97. Precision studies yielded an interassay CV of 6.4% in the intermediate range and 13% in the low range. Sensitivity was 0.69 int. unit/L. Cross reactivity was 1 to 2% with specimens fortified with lutropin or follitropin. The only substantial problem was with linearity in the upper part of the standard curve, especially in the interval, 100-200 int. units/L. This problem is obviated by adequate sample dilution.

Evidence that the alpha-subunit influences the specificity of receptor binding of the equine gonadotrophins

1997 ◽  
Vol 155 (2) ◽  
pp. 241-245 ◽  
Author(s):  
M Chopineau ◽  
N Martinat ◽  
H Marichatou ◽  
C Troispoux ◽  
C Auge-Gouillou ◽  
...  
Keyword(s):  
Receptor Binding ◽  
Molecular Basis ◽  
Binding Specificity ◽  
Chorionic Gonadotrophin ◽  
Beta Subunit ◽  
Alpha Subunit ◽  
Beta Hcg ◽  
In Vitro Bioassays ◽  
Receptor Binding Specificity

Horse LH/chorionic gonadotrophin (eLH/CG) exhibits, in addition to its normal LH activity, a high FSH activity in all other species tested. Donkey LH/CG (dkLH/CG) also exhibits FSH activity in other species, but about ten times less than the horse hormone. In order to understand the molecular basis of these dual gonadotrophic activities of eLH/CG and dkLH/CG better, we expressed, in COS-7 cells, hybrids between horse and donkey subunits, between horse or donkey alpha-subunit and human CG beta (hCG beta), and also between the porcine alpha-subunit and horse or donkey LH/CG beta. The resultant recombinant hybrid hormones were measured using specific FSH and LH in vitro bioassays which give an accurate measure of receptor binding specificity and activation. Results showed that it is the beta-subunit that determines the level of FSH activity, in agreement with the belief that it is the beta-subunit which determines the specificity of action of the gonadotrophins. However, donkey LH/CG beta combined with a porcine alpha-subunit exhibited no FSH activity although it showed full LH activity. Moreover, the hybrid between horse or donkey alpha-subunit and hCG beta also exhibited only LH activity. Thus, the low FSH activity of dkLH/CG requires an equine (donkey or horse) alpha-subunit combined with dkLH/CG beta. These results provide the first evidence that an alpha-subunit can influence the specificity of action of a gonadotrophic hormone.

scholarly journals Molecular-mass heterogeneity of Griffonia simplicifolia lectin IV subunits. Differences in the oligosaccharide moieties in the N-terminal region

1990 ◽  
Vol 272 (2) ◽  
pp. 343-350 ◽  
Author(s):  
P V Nikrad ◽  
J R Pearlstone ◽  
M R Carpenter ◽  
R U Lemieux ◽  
L B Smillie
Keyword(s):  
Monosaccharide Composition ◽  
Unique Sequence ◽  
Beta Subunit ◽  
The Other ◽  
Alpha Subunit ◽  
Sequence Analyses ◽  
Griffonia Simplicifolia ◽  
Sds Page ◽  
Dimeric Protein ◽  
Covalently Linked

Lectin IV of Griffonia simplicifolia (Mr approximately 56,000), which has a strong affinity for both the Lewis b and Y blood-group determinants, is a dimeric protein of two subunits, alpha (29 kDa) and beta (27 kDa), separable by SDS/PAGE and containing covalently linked oligosaccharide. After digestion with N-glycanase, the protein migrates as a single band with a mobility identical with that of the beta-subunit. After cleavage with hydroxylamine of 3H-labelled, but otherwise intact, lectin, the radioactively labelled oligosaccharide was found to be associated with two blocked N-terminal peptides separable by h.p.l.c. and having identical amino acid compositions. One of these had three or four glucosamine residues per molecule, whereas the other had only one or two. Sequence analyses of these, as well as of a 21 kDa hydroxylamine-cleaved fragment and of the intact lectin pretreated with pyroglutamate aminopeptidase, have provided a unique sequence for residues 1-62 of the two subunits. Evidence is presented for two sites of N-linked oligosaccharide attachment at Asn-5 and Asn-18. Whereas the alpha-subunit has oligosaccharide linked to both sites, the beta-subunit has carbohydrate associated with only one (Asn-18). Sugar analyses of the whole lectin reveal a monosaccharide composition of (Xyl)3(Fuc)2(Man)10(GlcNAc)6, representing 6.4% of the mass of the molecule. Taken together with the susceptibility of the Asn-5 linkage (but not of Asn-18) to N-glycanase digestion, the observations indicate that the structures of the oligosaccharides at residues 5 and 18 are different.

Choriogonadotropin and its beta subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays.

1988 ◽  
Vol 34 (9) ◽  
pp. 1758-1762 ◽  
Author(s):  
H Alfthan ◽  
J Schröder ◽  
R Fraser ◽  
A Koskimies ◽  
H Halila ◽  
...  
Keyword(s):  
Hydrophobic Interaction ◽  
Hydrophobic Interaction Chromatography ◽  
Menstrual Period ◽  
Beta Subunit ◽  
Last Menstrual Period ◽  
Time Resolved ◽  
Vitro Fertilization ◽  
Human Choriogonadotropin ◽  
Beta Hcg

Abstract Concentrations of human choriogonadotropin (hCG) and its free beta subunit (beta hCG) were measured in serum by highly sensitive and specific time-resolved immunofluorometric assays (IFMAS). The results were confirmed by completely separating beta hCG and hCG by a novel method based on hydrophobic-interaction chromatography. We used three monoclonal antibodies in two different combinations. In both assays an antibody reacting with both free beta hCG and with intact hCG was immobilized onto the wall of a microtiter strip well. For assay of intact hCG we used as the indicator antibody an antibody against the alpha subunit, labeled with a europium chelate. For assay of beta hCG we used an indicator antibody that reacted only with the free beta subunit. hCG cross-reacted in the assay of beta hCG by 0.6%. Quantifying hCG in serum after in vitro fertilization showed that, seven to eight days after embryo transfer, the hCG concentration started to increase, thereafter increasing with a doubling time of 1.9 days during the following three weeks. hCG concentrations in serum peaked six to 10 weeks later, corresponding to eight to 12 weeks after the last menstrual period. Throughout pregnancy, measurable amounts of beta hCG were present in serum. The highest beta hCG/hCG ratio (maximum 7.3%, median 3.0%) was observed during early gestation. During the fourth to 13th weeks after the last menstrual period the ratio of beta hCG/hCG decreased gradually, being 1.0% during the second and third trimesters.

Two-Site Immunoradiometric Assay of Intact Salmon Calcitonin

1992 ◽  
Vol 38 (11) ◽  
pp. 2284-2286 ◽  
Author(s):  
L J Deftos
Keyword(s):  
Monoclonal Antibodies ◽  
Detection Limit ◽  
Incubation Time ◽  
Salmon Calcitonin ◽  
Assay System ◽  
The Other ◽  
Polystyrene Bead ◽  
Immunoradiometric Assay ◽  
Peptide Fragments ◽  
Assay Format

Abstract We developed a two-site immunoradiometric assay (IRMA) of salmon calcitonin (SCT) that detects intact SCT(1-32) and not peptide fragments of the hormone. This was accomplished by using monoclonal antibodies prepared against the peptide fragments SCT(1-11) and SCT(11-32). Two antibodies with specificity for each of the peptides were purified from their respective ascites and evaluated in a two-site format wherein one of the antibodies was adsorbed to polystyrene beads and the other was radioiodinated. In this assay format, the antibody pair detected intact SCT(1-32) but did not react with either SCT(1-11) or SCT(11-32). The sensitivity of the assay could be increased by exchanging the antibodies with respect to bead adsorption and radioiodination. Furthermore, by increasing the incubation time and volume of incubation of sample with the polystyrene-bead-adsorbed antibody, the effective detection limit of the assay could be improved. This assay system can be used to detect intact SCT when the presence of fragments of the hormone might otherwise complicate interpretation of assay data.

Improved measurement of free alpha subunit of glycoprotein hormones by assay with use of a monoclonal antibody.

1988 ◽  
Vol 34 (10) ◽  
pp. 2022-2025 ◽  
Author(s):  
R W Whitcomb ◽  
J S Sangha ◽  
A L Schneyer ◽  
W F Crowley
Keyword(s):  
Monoclonal Antibody ◽  
Detection Limit ◽  
Cross Reactivity ◽  
Assay System ◽  
Beta Subunit ◽  
Alpha Subunit ◽  
Glycoprotein Hormones ◽  
Sensitive Assay ◽  
Precise Information ◽  
Sensitive Method

Abstract Any exploration of the physiology of secretion of free alpha subunit of glycoprotein hormones in humans requires a sensitive assay system that shows low cross reactivity with the intact hormones (lutropin, follitropin, thyrotropin, and choriogonadotropin). We established and validated such an assay system with a monoclonal antibody for detection of free alpha subunit in serum with better sensitivity (detection limit, 30 ng/L) and less cross reactivity (0.67% with intact human lutropin) than with available polyclonal antibody methods. Thus, the specific epitope recognized by this antibody apparently is exposed only on the free or uncombined form of alpha subunit and is concealed after non-covalent combination with any beta subunit. Using Western blot analysis, we show that most of the cross reactivity is probably the result of contamination of the human lutropin standard (obtained from the National Hormone and Pituitary Program, NIH) with small amounts of free alpha subunit. With such a specific and sensitive method, it should be possible to obtain more-precise information regarding the secretion of free alpha subunit.

Sign in / Sign up

Export Citation Format

Share Document